サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435063

抗不安薬市場：タイプ、剤形、投与経路、適応症、流通チャネル別-世界予測2024-2030年

Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
抗不安薬市場：タイプ、剤形、投与経路、適応症、流通チャネル別-世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗不安薬市場規模は2023年に12億4,000万米ドルと推計され、2024年には13億2,000万米ドルに達し、CAGR 7.27%で2030年には20億3,000万米ドルに達すると予測されます。

抗不安薬の世界市場

主な市場の統計
基準年[2023］ 12億4,000万米ドル
予測年[2024］ 13億2,000万米ドル
予測年 [2030] 20億3,000万米ドル
CAGR（%） 7.27%
抗不安薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは抗不安薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗不安薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-抗不安薬市場の市場規模および予測は？

2-抗不安薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-抗不安薬市場における技術動向と規制の枠組みは？

4-抗不安薬市場における主要ベンダーの市場シェアは？

5-抗不安薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人々の不安障害の有病率とメンタルヘルスと治療に対する意識の増加
      • 麻酔における鎮静剤としての抗不安薬の出現
    • 抑制要因
      • 抗不安薬の長期使用後の副作用に関連する問題
    • 機会
      • 製薬分野における抗不安薬の技術進歩
      • 精神的健康と幸福を促進するための政府の取り組みの増加
    • 課題
      • 精神障害に伴う社会的偏見に関連した問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 抗不安薬市場：タイプ別

  • 抗うつ薬
  • 抗ヒスタミン薬
  • アザピロネス
  • ベンゾジアゼピン系
  • ベータブロッカー
  • 非ベンゾジアゼピン系薬剤
  • 鎮静催眠薬

第7章 抗不安薬市場：形態別

  • カプセル
  • タブレット

第8章 抗不安薬市場：投与経路別

  • オーラル
  • 非経口

第9章 抗不安薬市場適応症別

  • 全般性不安障害
  • パニック障害
  • 恐怖症
  • 心的外傷後ストレス障害（PTSD）

第10章 抗不安薬市場：流通チャネル別

  • オフライン
  • オンライン

第11章 南北アメリカの抗不安薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の抗不安薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの抗不安薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AbbVie Inc.
    • Accord Healthcare US
    • Akorn Operating Company LLC
    • Alvogen
    • Amneal Pharmaceuticals LLC
    • Apotex Inc.
    • AstraZeneca PLC
    • Bausch Health Companies Inc.
    • Dellwich Healthcare LLP
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline PLC
    • H. Lundbeck A/S
    • Hameln Pharma GmbH
    • Hikma Pharmaceuticals PLC
    • Johnson & Johnson Services, Inc.
    • Lifecare Neuro Products Limited
    • Lifegenix
    • Neurocon Inc.
    • Noreva Biotech
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANXIOLYTICS MARKET DYNAMICS
  • FIGURE 7. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANXIOLYTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANXIOLYTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANXIOLYTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANXIOLYTICS MARKET SIZE, BY AZAPIRONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANXIOLYTICS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANXIOLYTICS MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANXIOLYTICS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANXIOLYTICS MARKET SIZE, BY SEDATIVE-HYPNOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 14. ANXIOLYTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANXIOLYTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. ANXIOLYTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANXIOLYTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ANXIOLYTICS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANXIOLYTICS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANXIOLYTICS MARKET SIZE, BY PHOBIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANXIOLYTICS MARKET SIZE, BY POSTTRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. ANXIOLYTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANXIOLYTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. ANXIOLYTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-C002B1C994B7

[181 Pages Report] The Anxiolytics Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 7.27% to reach USD 2.03 billion by 2030.

Global Anxiolytics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.32 billion
Forecast Year [2030] USD 2.03 billion
CAGR (%) 7.27%
Anxiolytics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anxiolytics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anxiolytics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Antidepressants
    • Antihistamines
    • Azapirones
    • Benzodiazepines
    • Beta-blockers
    • Nonbenzodiazepines
    • Sedative-hypnotics
  • Form
    • Capsules
    • Tablets
  • Route of Administration
    • Oral
    • Parenteral
  • Indication
    • Generalized Anxiety Disorder
    • Panic Disorder
    • Phobias
    • Posttraumatic Stress Disorder (PTSD)
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anxiolytics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anxiolytics Market?

3. What are the technology trends and regulatory frameworks in the Anxiolytics Market?

4. What is the market share of the leading vendors in the Anxiolytics Market?

5. Which modes and strategic moves are suitable for entering the Anxiolytics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anxiolytics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
      • 5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
      • 5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems related to social-stigma associated with mental disorders
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anxiolytics Market, by Type

  • 6.1. Introduction
  • 6.2. Antidepressants
  • 6.3. Antihistamines
  • 6.4. Azapirones
  • 6.5. Benzodiazepines
  • 6.6. Beta-blockers
  • 6.7. Nonbenzodiazepines
  • 6.8. Sedative-hypnotics

7. Anxiolytics Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Anxiolytics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral

9. Anxiolytics Market, by Indication

  • 9.1. Introduction
  • 9.2. Generalized Anxiety Disorder
  • 9.3. Panic Disorder
  • 9.4. Phobias
  • 9.5. Posttraumatic Stress Disorder (PTSD)

10. Anxiolytics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Anxiolytics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Anxiolytics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Anxiolytics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AbbVie Inc.
    • 15.1.2. Accord Healthcare US
    • 15.1.3. Akorn Operating Company LLC
    • 15.1.4. Alvogen
    • 15.1.5. Amneal Pharmaceuticals LLC
    • 15.1.6. Apotex Inc.
    • 15.1.7. AstraZeneca PLC
    • 15.1.8. Bausch Health Companies Inc.
    • 15.1.9. Dellwich Healthcare LLP
    • 15.1.10. Eli Lilly and Company
    • 15.1.11. F. Hoffmann-La Roche Ltd.
    • 15.1.12. GlaxoSmithKline PLC
    • 15.1.13. H. Lundbeck A/S
    • 15.1.14. Hameln Pharma GmbH
    • 15.1.15. Hikma Pharmaceuticals PLC
    • 15.1.16. Johnson & Johnson Services, Inc.
    • 15.1.17. Lifecare Neuro Products Limited
    • 15.1.18. Lifegenix
    • 15.1.19. Neurocon Inc.
    • 15.1.20. Noreva Biotech
    • 15.1.21. Novartis AG
    • 15.1.22. Pfizer Inc.
    • 15.1.23. Sanofi S.A.
    • 15.1.24. Sun Pharmaceutical Industries Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing